Respiratory Infections

Adam Brufsky, MD, discusses the potential of multiple SARS-CoV-2 viral strains.

Researchers and epidemiologists are working tirelessly to understand clusters that shed new insight into transmission dynamics.

Today's trending stories in infectious disease news.

Miriam Isola, PhD, talks to us about the use of phone apps for COVID-19 contact tracing.

In all trial participants to date, the vaccine candidate led to seroconversion with binding antibody levels either at or above levels seen in convalescent sera.

Armand Balboni, MD, PHD, CEO of Appili Therapeutics, discusses work with favipiravir on a new front for the drug — the global search for COVID-19 treatment and prevention therapies.

New cases came to the attention of public health officials within Shulan on May 7.

A summary of Contagion's top stories for May 15, 2020.

Elizabeth Leung, PharmD, shares SIDP's educational efforts surrounding COVID-19 treatment.

A new first-of-its-kind global registry aimed at sharing real-time information on hospital care and ICU admissions could expand the scope of SARS-CoV-2 research.

A briefing on the day's top stories.

In an in vitro reconstituted human respiratory epithelium model, the investigational drug inhibited replication of the novel coronavirus.

In the first part of a discussion with the medical oncologist from UPMC Hillman Cancer Center, Brufsky discusses the potential role of hyperglycemia in severity of COVID-19.

Vaccine candidate mRNA-1273 has been granted Fast Track designation by the US FDA.

A summary of today's top stories.

A quick summary of the day's infectious disease headlines.

RSV causes thousands of deaths in children - why do some have more severe disease?

Rodney E. Rohde, PhD, discusses the challenges our shortage of medical laboratory specialists creates for the COVID-19 response.

Contact tracing allows epidemiological response by not only notifying people of exposure so they can quarantine, but also understanding potential exposure dynamics that allowed for disease transmission.

A brief summary of our daily coverage.

A quick video summary of today's COVID-19 headlines.

Moderna hopes to initiate phase 2 and late stage studies of its vaccine candidate, mRNA-1273, against COVID-19.

A quick summary of our daily COVID-19 coverage.

It is known that the type of respiratory specimen, sampling environmental factors, and time from symptom onset impact the sensitivity of rapid influenza diagnostic tests.

The data were released as part of the now-cancelled European Congress of Clinical Microbiology and Infectious Diseases.